Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Osteosarcoma study set to benefit dogs and children
“Comparative oncology - the study of cancer treatments in multiple species - has the potential to deliver tremendous medical advances" - Dr Timothy Fan.

Researchers to explore the combination of immunotherapy and radiation 

US researchers are conducting a study into whether a dog’s immune system could be stimulated to eliminate osteosarcoma.

The team at the University of Illinois College of Veterinary Medicine hope their findings could lead to advances in not only treating canine patients but children too.

Study co-investigator and veterinary oncologist Dr Timothy Fan said: “Because there are similarities between canine osteosarcoma and human paediatric osteosarcoma, finding better treatment options for this form of cancer is equally important.”

Osteosarcoma is a highly aggressive, malignant bone tumour that most often occurs in one of the limbs. The disease affects around 10,000 dogs each year in the US, most of which are large or giant breeds.

“The first sign owners typically notice in their pets is lameness,” says Dr Kim Selting who is also working on the study. “Animals may also have swelling in the area of the tumour. These areas can be warm and painful to the touch.”

Current treatment options for canine osteosarcoma are radiation, amputation, chemotherapy or a combination of these methods. The veterinary surgeon works with the owner to design a treatment plan, tailored to the individual, that focuses on quality of life.

In the study, the team will assess a treatment method that combines an immunostimulatory molecule called CPG ODN - a molecule that has already shown promise as a component of cancer vaccines - with high-precision radiation.

The study will take place in three parts, looking first at a cell model, then a mouse model to see how the CPG molecule works in real animals. The findings from these studies will then be used to develop treatments for a small pilot study involving dogs.

“Comparative oncology - the study of cancer treatments in multiple species - has the potential to deliver tremendous medical advances,” Dr Fan continues. “This field is exploding.

“The National Cancer Institute has designated Illinois and 21 other academic oncology programs as part of the Comparative Oncology Trials Consortium, which plays an important role in human cancer research.”

Become a member or log in to add this story to your CPD history

Dogs Trust announces winners of vet student awards

News Story 1
 Cambridge vet student James Jewkes has been awarded first place in the annual Dogs Trust EMS Awards, for his paper on the threat of exotic infectious diseases in rehoming centres. James will now go on a two-week placement at the WVS International Training Centre in South India.

Each year the awards allow vet students to gain hands-on experience during work placements at 13 of the charity’s rehoming centres, then submit reports on a relevant subject.  

Click here for more...
News Shorts
Former RCVS president to chair new Horse Welfare Board

Former RCVS president Barry Johnson has been appointed as the independent chair of a new Horse Welfare Board. Barry, who is also past chairman of World Horse Welfare, was selected by an industry panel including the British Horseracing Authority, the Racecourse Association and The Horsemen’s Group.

The welfare board aims to develop a new welfare strategy covering the whole racing industry. Mr Johnson said: “I’m very pleased to have been asked by racing to take on this role and by the sport’s commitment to continuous improvement in the welfare of racehorses."